VISN 4 MIRECC Pittsburgh Investigators and Mentors - Robert A. Sweet, M.D. - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.



Quick Links

Veterans Crisis Line Badge
My healthevet badge

VISN 4 MIRECC Pittsburgh Investigators and Mentors - Robert A. Sweet, M.D.

Robert A. Sweet, M.D.
MIRECC Role(s): MIRECC Co-Associate Director for Research, Fellowship Director (Physician Training Track), Fellowship Primary Mentor
Bio: Dr. Sweet is currently Professor of Psychiatry and Neurology at the University of Pittsburgh and Co-Associate Director for Research at the Mental Illness Research, Education, and Clinical Center (MIRECC), VA Pittsburgh Healthcare System (VAPHS). In addition to his role as MIRECC Fellowship Director (Physician Training Track), Dr. Sweet also directs a postdoctoral fellowship training program (T32) in the University of Pittsburgh Department of Psychiatry, focused on training in the translational neuroscience of mental illness.
He earned his B.S. in Biology from Rensselaer Polytechnic Institute and his M.D. from the University of Maryland. Dr. Sweet is a fellow of the American College of Neuropsychopharmacology and a member of the Society of Biologic Psychiatry, and is a Founding Member of the International College of Geriatric Psychoneuropharmacology.
He has received awards for his research and teaching, among them the 2005 Mentorship Award from the University of Pittsburgh Department of Psychiatry.
Research Interests: Dr. Sweet's research is focused on understanding the mechanisms which lead to the generation of psychotic symptoms which are core features of the prototypic psychotic disorder, schizophrenia, but also occur in about 50% of individuals with Alzheimer's disease. In his work, he has proposed that there are common genetic risk factors and vulnerable brain circuits that act together to cause positive symptoms across these disorders.